Forget a Cash ISA! I’d aim to make a passive income with these 2 FTSE 100 dividend stocks

I think these two FTSE 100 (INDEXFTSE:UKX) income shares appear to offer favourable prospects when compared to a Cash ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since the best returns available on a Cash ISA are currently around 1.5%, buying FTSE 100 dividend shares could prove to be a shrewd move.

In many cases, it is possible to double, or even treble, your passive income when compared to Cash ISA rates.

With interest rates set to remain at their current level, or even fall, over the next few years, now could be a good time to buy these two large-cap income shares. They appear to have sound strategies that could produce capital growth alongside their income returns.

AstraZeneca

With a 3.1% dividend yield, AstraZeneca (LSE: AZN) may not be among the highest-yielding shares in the FTSE 100. However, the pharmaceutical company’s dividend growth prospects could make it a sound income opportunity for the long run.

Its recent updates have shown that its pipeline has improved dramatically in recent years after an ambitious investment programme. This could position the company for growth in a world where demographic challenges may catalyse demand for a wide range of healthcare products and services.

AstraZeneca’s defensive business model may prove to be attractive to many investors during what is a period of significant economic and political risk.

Furthermore, with its dividend expected to be covered 1.3 times by net profit in the current year, there seems to be scope for its shareholder payouts to rise at a brisk pace. This could lead to a strong and dependable passive income stream for its investors that catalyses its share price over the long run.

British Land

Real estate investment trust (REIT) British Land (LSE: BLND) is a very different investment proposition than AstraZeneca. The property company is facing a period of disruption across much of its asset base, with demand for retail units expected to come under pressure over the medium term as online shopping becomes increasingly popular.

This could cause rents to decline, which may put the company’s dividend growth rate under a degree of pressure. However, with British Land shifting its focus away from retail and towards faster-growing areas such as flexible office space, it seems to have a sound strategy that could lead to improving financial performance in the long run.

Furthermore, investors appear to have factored in the risks facing the business. It trades on a price-to-book (P/B) ratio of just 0.6, while its dividend yield of 5.4% is among the highest yields currently available in the FTSE 100.

Certainly, British Land may prove to be a relatively risky stock to own in the short run, as it aims to transition towards assets that have greater growth potential. For long-term income investors, now could be the right time to buy a slice of the business based on its high income return and wide margin of safety. It could offer high total returns in the coming years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and British Land Co. The Motley Fool UK has recommended AstraZeneca and British Land Co. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Growth Shares

2 growth shares that could help push the FTSE 100 to 9,000 points this year

Jon Smith flags up the surge in the FTSE 100 and outlines two growth shares that he feels could help…

Read more »

Young female analyst working at her desk in the office
Investing Articles

Airtel Africa’s share price sinks on profits hit! Time to buy?

Airtel Africa's share price has plunged as news of currency devaluations spook investors. Is this a great dip buying opportunity?

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

What are the best AI stocks to buy for explosive growth potential?

Oliver Rodzianko thinks there are many great AI stocks to buy, even after all the hype. He believes robotics could…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£20,000 in savings? Here’s how I’d aim for £17,896 in income with FTSE 100 shares

Our writer explains how he’d try to turn a lump sum into a five-figure income stream by investing in FTSE…

Read more »

Illustration of flames over a black background
Investing Articles

Up 70% in a year! Is it time I finally bought this red-hot UK stock?

Harvey Jones is always on the hunt for a dirt cheap UK stock with recovery potential. But should he buy…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

1 potential takeover target in the FTSE 250

This FTSE 250 stock’s down 52% over the last year, leaving Ben McPoland to wonder whether it could soon exit…

Read more »

Young black woman using a mobile phone in a transport facility
Investing Articles

Down 15% this year, are Airtel Africa shares a bargain?

Airtel Africa shares fell today after the company published results showing an annual loss. Shareholder Christopher Ruane looks at what's…

Read more »

Hand arranging wood block stacking as step stair on paper pink background
Investing Articles

£20,000 in savings? Here’s how I’d aim to turn that into a £16,075 annual second income

This FTSE 100 stock pays a high dividend that could make me a big second income. It looks undervalued and…

Read more »